XM tidak menyediakan perkhidmatan kepada penduduk Amerika Syarikat.

Wall Street set to fall as megacap chip, tech stocks tumble



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>US STOCKS-Wall Street set to fall as megacap chip, tech stocks tumble</title></head><body>

Chip stocks slump on China trade worries, tech rout

J&J flat after cutting annual profit forecast

Lilly down as rival Roche reports early data for obesity pill

Spirit Airlines shares slip after lowered Q2 forecast

Futures down: Dow 0.28%, S&P 500 0.96%, Nasdaq 1.46%

Updated at 8:40 a.m. Et/1240 GMT

By Lisa Pauline Mattackal and Ankika Biswas

July 17 (Reuters) - Indexes were set to open lower on Wednesday, as declines in major chip and tech stocks led broad-based market losses amid a slew of corporate results and the prospect of tougher U.S. trade restrictions being imposed on Chinese chips.

A report that theBiden Administration was considering severetrade restrictions as part of a chip clampdown against China weighed on semiconductor stocks in premarket trading.

AI-chip favorite Nvidia NVDA.O tumbled3.8%, while ASML's U.S.-listing ASML.O lost8.2%.

In other moves, U.S.-listed shares of Taiwan Semiconductor Manufacturing TSM.N shed6.0% after Republican presidential candidate Donald Trump said Taiwan should pay the U.S. for its defense.

Marvell Technology MRVL.O, Broadcom AVGO.O, Qualcomm QCOM.O, Micron Technology MU.O, Advanced Micro Devices AMD.O and Arm Holdings ARM.O were also down between 3% and 4.7%.

All the so-called "Magnificent Seven" megacap stocks slumped, with Apple AAPL.O, Microsoft MSFT.O Meta Platforms META.O and Tesla TSLA.O down between 1% and 2.1%.

The possibility of a fresh crackdown on China trade could be the negative trigger investors were waiting for to start booking profits in tech stocks, according to Ahmed Azzar, financial market analyst at Equiti Group.

Futures tracking the Russell 2000 RTYcv1 fell0.6% after the small-cap index .RUT rallied nearly 12% over the last five sessions.

Signaling growing investor unease,Wall Street's "fear gauge" .VIX was trading at its highest level in six weeks.

The Dow Jones Industrial Average .DJI and the S&P 500 .SPX had closed at all-time highs on Tuesday.

After a blistering rally in tech companies since the last leg of 2023, investors have begun moving out of expensive megacaps to underperforming areas of the market.

"I'm still optimistic that the market is not as expensive as maybe it's feared, but that's because we're so overbought that some near-term selling pressure is likely to develop," said Robert Pavlik, senior portfolio manager at Dakota Wealth, adding that he had also taken some profits in tech.

Firmer bets on a Fed rate cut in September as well as rising expectations that former President Donald Trump will be back in the White House in November following theattempt on his life havehelped lift stocks in the last few sessions.

Investors will focus on comments from Fed officials Thomas Barkin and Christopher Waller later in the day for clues on how policymakers have assessed recent economic data.

The New York Fed's John Williams said in an interview that the central bank was "getting closer" to a point where it could start cutting interest rates.

On the earnings front, J&J JNJ.N was flat, paring losses after the drug and devices maker lowered itsannual earnings forecast.

Industrial production data for June is also due before markets open.

At 8:40 a.m. ET, Dow e-minis 1YMcv1 were down 116 points, or 0.28%, S&P 500 e-minis EScv1 were down 55 points, or 0.96%, and Nasdaq 100 e-minis NQcv1 were down 300.75 points, or 1.46%.

Among others, U.S. drugmaker Eli Lilly LLY.N fell 3.4% after Swiss rival Roche's ROG.S promising early-stage data from anexperimental obesity pill.

Spirit Airlines SAVE.N slumped 4%after lowering its second-quarter revenue outlook, citing lower-than-expected non-ticket revenue.

Northern Trust NTRS.O rose 2.1% after the asset and wealth manager reported a jump in second-quarter profit on higher fees and an accounting gain.



Reporting by Lisa Mattackal and Ankika Biswas in Bengaluru; Editing by Pooja Desai

</body></html>

Penafian: Entiti XM Group menyediakan perkhidmatan pelaksanaan sahaja dan akses ke Kemudahan Dagangan Atas Talian, yang membolehkan sesorang melihat dan/atau menggunakan kandungan yang ada di dalam atau melalui laman web, tidak bertujuan untuk mengubah atau memperluas, juga tidak mengubah atau mengembangkannya. Akses dan penggunaan tersebut tertakluk kepada: (i) Terma dan Syarat; (ii) Amaran Risiko; dan Penafian Penuh. Oleh itu, kandungan sedemikian disediakan tidak lebih dari sekadar maklumat umum. Terutamanya, perlu diketahui bahawa kandungan Kemudahan Dagangan Atas Talian bukan permintaan, atau tawaran untuk melakukan transaksi dalam pasaran kewangan. Berdagang dalam mana-mana pasaran kewangan melibatkan tahap risiko yang besar terhadap modal anda.

Semua bahan yang diterbitkan di Kemudahan Dagangan Atas Talian kami bertujuan hanya untuk tujuan pendidikan/maklumat dan tidak mengandungi – dan tidak boleh dianggap mengandungi nasihat kewangan, cukai pelaburan atau dagangan dan cadangan, atau rekod harga dagangan kami, atau tawaran, atau permintaan untuk suatu transaksi dalam sebarang instrumen kewangan atau promosi kewangan yang tidak diminta kepada anda.

Sebarang kandungan pihak ketiga serta kandungan yang disediakan oleh XM, seperti pendapat, berita, penyelidikan, analisis, harga, maklumat lain atau pautan ke laman web pihak ketiga yang terdapat dalam laman web ini disediakan berdasarkan "seadanya" sebagai ulasan pasaran umum dan bukanlah nasihat pelaburan. Sesuai dengan apa-apa kandungan yang ditafsir sebagai penyelidikan pelaburan, anda mestilah ambil perhatian dan menerima bahawa kandungan tersebut tidak bertujuan dan tidak sediakan berdasarkan keperluan undang-undang yang direka untuk mempromosikan penyelidikan pelaburan bebas dan oleh itu, ia dianggap sebagai komunikasi pemasaran di bawah peraturan dan undang-undang yang berkaitan. SIla pastikan bahawa anda telah membaca dan memahami Notifikasi mengenai Penyelidikan Pelaburan Bukan Bebas dan Amaran Risiko mengenai maklumat di atas yang boleh diakses di sini.

Amaran Risiko: Modal anda dalam risiko. Produk yang berleveraj mungkin tidak sesuai untuk semua individu. Sila pertimbangkan Pendedahan Risiko kami.